Search

everythinglearnresearchcommunity

for

Search:↓

Hairless protein can block vitamin D activation in skin cells.

Vitiligo and alopecia areata may have similar causes despite their differences.

Early diagnosis and a strict gluten-free diet are crucial for children with celiac disease to improve symptoms.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Hydrogels show promise for scarless wound healing by reducing skin fibrosis.

Wound healing is not fully understood, requiring more research and collaboration to improve treatments.

Advanced technologies can improve understanding and monitoring of skin-brain interactions.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Pertussis toxin may contribute to hair loss in alopecia areata.

Topical minoxidil effectively stimulates hair growth in men with hair loss.

Finasteride may lower cholesterol and slow heart disease progression.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The right cells and signals can potentially lead to scarless wound healing, with a mix of natural and external wound healing controllers possibly being the best way to achieve this.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.